Results 191 to 200 of about 31,621 (232)
Some of the next articles are maybe not open access.
Plasmapheresis in the Dysproteinemias
Therapeutic Apheresis, 2002Abstract: The dysproteinemias consist of a broad range of serious disease states with the common thread of excessive production of an abnormal, or para‐protein. Various clinical syndromes may arise, either from the underlying disease process, the excess paraprotein, or both.
openaire +2 more sources
Plasmapheresis Therapy in Macroglobulinemia
Annals of Internal Medicine, 1962Excerpt A marked increase in serum viscosity may be responsible for many of the disease manifestations of pathologic states associated with elevated serum macroglobulin levels.
A, SOLOMON, J L, FAHEY
openaire +2 more sources
Removal of Basiliximab by Plasmapheresis
American Journal of Kidney Diseases, 2001Basiliximab is a chimeric monoclonal antibody directed against the alpha chain of interleukin-2 (IL-2) receptors. Given its expected volume of distribution (plasma volume), therapeutic plasmapheresis may be expected to lower serum Basiliximab levels. A 20-mg dose of Basiliximab was given before plasmapheresis.
C N, Okechukwu +5 more
openaire +2 more sources
Transfusion and Apheresis Science
The increased need for source plasma in the production of plasma-derived medical products has received attention and elicited diverse actions in Europe lately. The discrepancy between production and utilization poses ethical as well as medical questions to be discussed in the international community. The contribution of non-remunerated voluntary donors
openaire +2 more sources
The increased need for source plasma in the production of plasma-derived medical products has received attention and elicited diverse actions in Europe lately. The discrepancy between production and utilization poses ethical as well as medical questions to be discussed in the international community. The contribution of non-remunerated voluntary donors
openaire +2 more sources
DeckerMed Nephrology, Dialysis, and Transplantation, 2002
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +1 more source
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +1 more source